MENLO PARK

Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101 for the Treatment of Mono- and Multi-Food Allergies

Retrieved on: 
Wednesday, November 22, 2023
Biologics license application, Empoasca decipiens, Allergen, Food, FDA, OIT, Salmon, Peanut, Letter, Immunoglobulin E, Food allergy, American College, Hazelnut, ACAAI, Patient, Safety, Data collection, Harmony, Therapy, Fast Track, BLA, Pharmaceutical industry

MENLO PARK, Calif., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Alladapt Immunotherapeutics, Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, today announced that ADP101, its investigational multi-food oral immunotherapy (mOIT) designed to simultaneously treat allergy to one or more of the world’s most significant food allergens, received Fast Track Designation from the U.S. Food and Drug Administration (FDA). ADP101 is the most advanced multi-food OIT pharmaceutical candidate in development.

Key Points: 
  • Our team is thrilled to be at the forefront of developing a new treatment that addresses such a huge unmet need.
  • FDA’s Fast Track program is designed to expedite the development of new drugs intended to treat serious or life-threatening conditions.
  • Fast Track allows more frequent meetings and written communications with FDA to discuss the drug's development plan, clinical trial design, and data collection.
  • Alladapt is also conducting the Encore Study, an open-label extension study of the Harmony study assessing long term use of ADP101 in mono- and multi-food allergic patients.

Joshu Strengthens Its Executive Roster

Retrieved on: 
Thursday, November 16, 2023
Fintech, Insurance, DRC, Policy, Management, Growth, Jōshū

Burkhart is an insurance industry veteran who joins Joshu with an impressive sales and operations career spanning several decades.

Key Points: 
  • Burkhart is an insurance industry veteran who joins Joshu with an impressive sales and operations career spanning several decades.
  • Before coming to Joshu, Burkhart managed relationships at Decision Research Corporation (DRC) and was a Segment Lead within the Specialty Division at Berkley Technology Services.
  • In his new role as vice president of growth at Joshu, Burkhart will be dedicated to driving the company’s growth objectives and partnerships.
  • “Expanding our executive team with Mark has proven to be pivotal to our success and a breakthrough year.

Menlo Ventures Closes $1.35 Billion to Invest in Companies Leading the AI Transformation

Retrieved on: 
Thursday, November 16, 2023
Human, Generative, CPO, Investment, Anthropization, Siri, Uber, Ecosystem, Harness, Menlo Ventures, AI, Roku, Name, Enterprise, Cryptocurrency, Sales, Atlassian, Conifer cone

MENLO PARK, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Today, Menlo Ventures , a leading venture capital firm, announced the firm has raised $1.35 billion in new capital that will be invested by Menlo’s flagship venture fund Menlo XVI and Menlo Inflection III and their affiliated funds, with a mandate to invest in promising technology companies leading the AI transformation.

Key Points: 
  • MENLO PARK, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Today, Menlo Ventures , a leading venture capital firm, announced the firm has raised $1.35 billion in new capital that will be invested by Menlo’s flagship venture fund Menlo XVI and Menlo Inflection III and their affiliated funds, with a mandate to invest in promising technology companies leading the AI transformation.
  • “With this $1.35 billion in new capital, we’re making a commitment to support the forthcoming generation of AI startups,” said Venky Ganesan.
  • Menlo Ventures will help write the next chapter,” said Matt Murphy, partner at Menlo Ventures.
  • The potential is profound.”
    To learn more about Menlo Ventures, please visit www.menlovc.com
    For detail on Menlo Ventures’ perspective on AI, visit https://menlovc.com/focus-areas/ai/
    To read Menlo Venture’s newest report, The State of Generative AI in the Enterprise visit mnlo.vc/Ent_AI_Report

Robinhood Markets, Inc. Reports October 2023 Operating Data

Retrieved on: 
Wednesday, November 15, 2023
Crypto, Robinhood Markets, Net, AUC, NCFA, Cryptocurrency, Custody

MENLO PARK, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported selected monthly operating data for October 2023:

Key Points: 
  • MENLO PARK, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported selected monthly operating data for October 2023:
    Net Cumulative Funded Accounts (NCFA) at the end of October were 23.3 million, up approximately 30 thousand from September 2023(1).
  • Assets Under Custody (AUC) at the end of October were $84.6 billion, down 2% from September 2023.
  • Net Deposits were $1.0 billion in October, translating to a 14% annualized growth rate relative to September 2023 AUC.
  • Cash Sweep Balances at the end of October were $13.9 billion, up $0.3 billion (2%) from the end of September 2023.

Menlo Ventures’ State of Generative AI in the Enterprise Reveals New Data on Sentiment and Adoption Rates, Highlighting Opportunities for Startups

Retrieved on: 
Monday, November 13, 2023
Generative, Engineering, Eating, Traction, Learning, Enterprise report management, Research, Marketing, Horizontal, Human, Menlo Ventures, AI, Enterprise, LLM, Customer service, Dairy, Medical device

According to the report, enterprise investment in generative AI remains surprisingly small, totaling $2.5 billion this year–significantly less than the $70 billion invested in traditional AI and the $400 billion spent on cloud software.

Key Points: 
  • According to the report, enterprise investment in generative AI remains surprisingly small, totaling $2.5 billion this year–significantly less than the $70 billion invested in traditional AI and the $400 billion spent on cloud software.
  • The report identifies three areas that offer enormous potential for startups to break out:
    Vertical AI: Research shows that the marketing and legal industries currently lead the way in vertical generative AI adoption.
  • The modern AI stack: New generative capabilities require new tools for building LLM apps, including databases, serving infrastructure, data orchestration, and pipelines.
  • Although still a “work in progress,” the modern AI stack attracts the largest percentage of enterprise AI investment, making it the biggest new market in the generative AI domain and an attractive focus for startups.

citizenM Menlo Park Hotel Jointly Built by CIMC Group Officially Opened in Silicon Valley, USA

Retrieved on: 
Monday, December 11, 2023
Carbon, Glass, Pressure, Fire blanket, Urban renewal, Dust, National Fenestration Rating Council, Gold, Government, Learning, MBS, Certification, Silicon, Multimedia, Air conditioning, Postgraduate education, APP, City, DTLA, Quality control, Stanford University, Seismicity, University, Pacific Ocean, CIMC, Heat, CitizenM, Environment, Apple, NFRC, Noise, LEGO, Prefabrication, Hotel, Construction

SHENZHEN, China, Dec. 10, 2023 /PRNewswire/ -- Recently, the iconic citizenM Menlo Park Hotel, officially opened.

Key Points: 
  • SHENZHEN, China, Dec. 10, 2023 /PRNewswire/ -- Recently, the iconic citizenM Menlo Park Hotel, officially opened.
  • The volumetric modules for the project were provided by CIMC Modular Building Holding Company Limited ("CIMC MBS"), a subsidiary of CIMC Construction Technology Company Limited of CIMC Group.
  • The citizenM Menlo Park Hotel, developed by the internationally renowned boutique hotel chain citizenM, and is located in Silicon Valley, the hub of high-tech companies in the US.
  • Both the citizenM Menlo Park Hotel and the citizenM DTLA Hotel are located in high seismic intensity zones in the US.

Alladapt Immunotherapeutics Presents Phase 1/2 Harmony Data Demonstrating Therapeutic Potential and Safety of ADP101 for the Treatment of Food Allergy at 2023 ACAAI Annual Meeting

Retrieved on: 
Thursday, November 9, 2023
Patient, Anaphylaxis, FDA, American College, Food allergy, Health care, Therapy, Salmon, Literature, ACAAI, Adrenaline, Food, Safety, Maintenance, Poster, ID, Convention, Immunoglobulin E, Harmony, Allergen, National Primate Research Exhibition Hall, OIT, BLA, Pharmaceutical industry, Allergy, Encore, Immunology

MENLO PARK, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Alladapt Immunotherapeutics, Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, today announced that data from the Phase 1/2 Harmony study will be presented at the 2023 Annual Scientific Meeting of the American College of Asthma, Allergy and Immunology (ACAAI) taking place Nov. 9-13. The data demonstrate that ADP101, an investigational multi-allergen oral immunotherapy (OIT), generated dose-dependent, clinically meaningful responses, and a favorable safety and tolerability profile in pediatric patients allergic to one or more of the food sources in the product. This is the first time these data have been presented in the United States.

Key Points: 
  • Ashley Dombkowski, Ph.D., Chief Executive Officer and Co-Founder of Alladapt, said, “We are excited to present the encouraging Phase 1/2 safety and efficacy data from our Harmony study at ACAAI.
  • The Harmony data underscore the value of our multi-allergen approach and the potential for ADP101 to address a profound unmet need for patients and their families.
  • Alladapt is also conducting the Encore Study, an open-label extension study of the Harmony study assessing long term use of ADP101.
  • Data from Encore are expected to be reported on an annual basis with the first results anticipated in early 2024.

Robinhood Reports Third Quarter 2023 Results

Retrieved on: 
Tuesday, November 7, 2023
Crypto, Adjustment, Active users, AUC, ARPU, SBC, MAU, Cryptocurrency, EBITDA, IRA, Fraud, Robinhood Markets, GAAP, Gold, Acquisition, Entrepreneurship, Growth, EPS, ETF, Net, Investment, Movement, Securities lending, EU, Bank, Financial services, Automotive industry, Video game, Beauty salon, Q3

MENLO PARK, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced financial results for the third quarter of 2023, which ended September 30, 2023.

Key Points: 
  • MENLO PARK, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced financial results for the third quarter of 2023, which ended September 30, 2023.
  • Q3 2023 EPS of -$0.09 included -$0.11 per share impact from a regulatory accrual of $104 million.
  • Robinhood will host a conference call to discuss its results at 2 p.m. PT / 5 p.m.
  • Based on our Q3 2023 results, our expense outlook for 2023 has changed from our prior outlook at Q2 2023 earnings (August 2, 2023).

Sight Sciences Reports Third Quarter 2023 Financial Results and Withdraws Guidance for Full Year 2023

Retrieved on: 
Tuesday, November 7, 2023
Telecanthus, EEG microstates, Trial of the century, OMNI, LCD, WPS, Ophthalmology, Medicare, MIGS, Macs, Congress, IOP, Publication, GAAP, Nature, Environment, News, Growth, Cataract, Clinical trial, Surgeon, American Academy, Webcast, London, Refraction, European Society of Clinical Microbiology and Infectious Diseases, Centers for Medicare & Medicaid Services, Patient, GEMINI, Pharmaceutical industry, Video game, Ciclosporin

Generated third quarter 2023 total revenue of $20.0 million, an increase of 7% compared to the same period in the prior year.

Key Points: 
  • Generated third quarter 2023 total revenue of $20.0 million, an increase of 7% compared to the same period in the prior year.
  • Achieved total gross margin of 86.6% in the third quarter of 2023 compared to 84.3% in the same period in the prior year.
  • On October 26, 2023, WPS Government Health Administrators (“WPS”), a Medicare Administrative Contractor (“MAC”), published an LCD with an effective date of December 24, 2023.
  • Sight Sciences' management team will host a conference call today, November 7, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

The Wiggles Enter into Agreement with Future Today’s HappyKids to Add Classic Content to the Platform

Retrieved on: 
Tuesday, November 7, 2023
Dance, Luke Field, Family, The Beatles, Season, Magic, Running, Music, AVOD, Toy, The Wiggles, Tsehay Hawkins

MENLO PARK, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Wiggles, the longest running and most beloved children’s entertainment group, and HappyKids , Future Today’s free ad-supported streaming service, have entered into an agreement to add more than 80 hours of classic Wiggles content to the HappyKids Channel.

Key Points: 
  • MENLO PARK, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Wiggles, the longest running and most beloved children’s entertainment group, and HappyKids , Future Today’s free ad-supported streaming service, have entered into an agreement to add more than 80 hours of classic Wiggles content to the HappyKids Channel.
  • In addition, Future Today will be creating and distributing a Wiggles-branded App featuring both the classic content and two seasons of new content from their latest series “Ready, Steady, Wiggle” (Seasons 4 & 5, 26x11 each).
  • The announcement was made jointly today by Luke Field, General Manager of The Wiggles, and David DiLorenzo, SVP Kids & Family of Future Today.
  • Luke Field comments, “We are thrilled that the incredible world of The Wiggles will be accessible to the ever-expanding HappyKids audience.